865 related articles for article (PubMed ID: 31899206)
1. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.
Ma HY; Yamamoto G; Xu J; Liu X; Karin D; Kim JY; Alexandrov LB; Koyama Y; Nishio T; Benner C; Heinz S; Rosenthal SB; Liang S; Sun M; Karin G; Zhao P; Brodt P; Mckillop IH; Quehenberger O; Dennis E; Saltiel A; Tsukamoto H; Gao B; Karin M; Brenner DA; Kisseleva T
J Hepatol; 2020 May; 72(5):946-959. PubMed ID: 31899206
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice.
Meng F; Wang K; Aoyama T; Grivennikov SI; Paik Y; Scholten D; Cong M; Iwaisako K; Liu X; Zhang M; Österreicher CH; Stickel F; Ley K; Brenner DA; Kisseleva T
Gastroenterology; 2012 Sep; 143(3):765-776.e3. PubMed ID: 22687286
[TBL] [Abstract][Full Text] [Related]
3. STARD1 promotes NASH-driven HCC by sustaining the generation of bile acids through the alternative mitochondrial pathway.
Conde de la Rosa L; Garcia-Ruiz C; Vallejo C; Baulies A; Nuñez S; Monte MJ; Marin JJG; Baila-Rueda L; Cenarro A; Civeira F; Fuster J; Garcia-Valdecasas JC; Ferrer J; Karin M; Ribas V; Fernandez-Checa JC
J Hepatol; 2021 Jun; 74(6):1429-1441. PubMed ID: 33515644
[TBL] [Abstract][Full Text] [Related]
4. Lack of FGF21 promotes NASH-HCC transition
Zheng Q; Martin RC; Shi X; Pandit H; Yu Y; Liu X; Guo W; Tan M; Bai O; Meng X; Li Y
Theranostics; 2020; 10(22):9923-9936. PubMed ID: 32929325
[No Abstract] [Full Text] [Related]
5. Transforming growth factor-β signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1.
Yang L; Inokuchi S; Roh YS; Song J; Loomba R; Park EJ; Seki E
Gastroenterology; 2013 May; 144(5):1042-1054.e4. PubMed ID: 23391818
[TBL] [Abstract][Full Text] [Related]
6. Macrophage p38α promotes nutritional steatohepatitis through M1 polarization.
Zhang X; Fan L; Wu J; Xu H; Leung WY; Fu K; Wu J; Liu K; Man K; Yang X; Han J; Ren J; Yu J
J Hepatol; 2019 Jul; 71(1):163-174. PubMed ID: 30914267
[TBL] [Abstract][Full Text] [Related]
7. ALDH2 deficiency promotes alcohol-associated liver cancer by activating oncogenic pathways via oxidized DNA-enriched extracellular vesicles.
Seo W; Gao Y; He Y; Sun J; Xu H; Feng D; Park SH; Cho YE; Guillot A; Ren T; Wu R; Wang J; Kim SJ; Hwang S; Liangpunsakul S; Yang Y; Niu J; Gao B
J Hepatol; 2019 Nov; 71(5):1000-1011. PubMed ID: 31279903
[TBL] [Abstract][Full Text] [Related]
8. TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms.
Esparza-Baquer A; Labiano I; Sharif O; Agirre-Lizaso A; Oakley F; Rodrigues PM; Zhuravleva E; O'Rourke CJ; Hijona E; Jimenez-Agüero R; Riaño I; Landa A; La Casta A; Zaki MYW; Munoz-Garrido P; Azkargorta M; Elortza F; Vogel A; Schabbauer G; Aspichueta P; Andersen JB; Knapp S; Mann DA; Bujanda L; Banales JM; Perugorria MJ
Gut; 2021 Jul; 70(7):1345-1361. PubMed ID: 32907830
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Inflammation by IL-17A and IL-17F Modulates Non-Alcoholic Fatty Liver Disease Pathogenesis.
Giles DA; Moreno-Fernandez ME; Stankiewicz TE; Cappelletti M; Huppert SS; Iwakura Y; Dong C; Shanmukhappa SK; Divanovic S
PLoS One; 2016; 11(2):e0149783. PubMed ID: 26895034
[TBL] [Abstract][Full Text] [Related]
10. IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation.
Tan Z; Qian X; Jiang R; Liu Q; Wang Y; Chen C; Wang X; Ryffel B; Sun B
J Immunol; 2013 Aug; 191(4):1835-44. PubMed ID: 23842754
[TBL] [Abstract][Full Text] [Related]
11. TLR2 and TLR9 contribute to alcohol-mediated liver injury through induction of CXCL1 and neutrophil infiltration.
Roh YS; Zhang B; Loomba R; Seki E
Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(1):G30-41. PubMed ID: 25930080
[TBL] [Abstract][Full Text] [Related]
12. The contribution of toll-like receptor signaling to the development of liver fibrosis and cancer in hepatocyte-specific TAK1-deleted mice.
Song IJ; Yang YM; Inokuchi-Shimizu S; Roh YS; Yang L; Seki E
Int J Cancer; 2018 Jan; 142(1):81-91. PubMed ID: 28875549
[TBL] [Abstract][Full Text] [Related]
13. Ezetimibe suppresses development of liver tumors by inhibiting angiogenesis in mice fed a high-fat diet.
Miura K; Ohnishi H; Morimoto N; Minami S; Ishioka M; Watanabe S; Tsukui M; Takaoka Y; Nomoto H; Isoda N; Yamamoto H
Cancer Sci; 2019 Feb; 110(2):771-783. PubMed ID: 30520543
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis.
Wang K; Kim MK; Di Caro G; Wong J; Shalapour S; Wan J; Zhang W; Zhong Z; Sanchez-Lopez E; Wu LW; Taniguchi K; Feng Y; Fearon E; Grivennikov SI; Karin M
Immunity; 2014 Dec; 41(6):1052-63. PubMed ID: 25526314
[TBL] [Abstract][Full Text] [Related]
15. Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features.
Zhu C; Ho YJ; Salomao MA; Dapito DH; Bartolome A; Schwabe RF; Lee JS; Lowe SW; Pajvani UB
J Hepatol; 2021 Mar; 74(3):613-626. PubMed ID: 33038431
[TBL] [Abstract][Full Text] [Related]
16. Absence of interleukin-17 receptor a signaling prevents autoimmune inflammation of the joint and leads to a Th2-like phenotype in collagen-induced arthritis.
Corneth OB; Mus AM; Asmawidjaja PS; Klein Wolterink RG; van Nimwegen M; Brem MD; Hofman Y; Hendriks RW; Lubberts E
Arthritis Rheumatol; 2014 Feb; 66(2):340-9. PubMed ID: 24504806
[TBL] [Abstract][Full Text] [Related]
17. NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice.
Liang S; Ma HY; Zhong Z; Dhar D; Liu X; Xu J; Koyama Y; Nishio T; Karin D; Karin G; Mccubbin R; Zhang C; Hu R; Yang G; Chen L; Ganguly S; Lan T; Karin M; Kisseleva T; Brenner DA
Gastroenterology; 2019 Mar; 156(4):1156-1172.e6. PubMed ID: 30445007
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte-specific TAK1 deficiency drives RIPK1 kinase-dependent inflammation to promote liver fibrosis and hepatocellular carcinoma.
Tan S; Zhao J; Sun Z; Cao S; Niu K; Zhong Y; Wang H; Shi L; Pan H; Hu J; Qian L; Liu N; Yuan J
Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14231-14242. PubMed ID: 32513687
[TBL] [Abstract][Full Text] [Related]
19. CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4
Mossanen JC; Kohlhepp M; Wehr A; Krenkel O; Liepelt A; Roeth AA; Möckel D; Heymann F; Lammers T; Gassler N; Hermann J; Jankowski J; Neumann UP; Luedde T; Trautwein C; Tacke F
Gastroenterology; 2019 May; 156(6):1877-1889.e4. PubMed ID: 30710528
[TBL] [Abstract][Full Text] [Related]
20. Regulation of gastric B cell recruitment is dependent on IL-17 receptor A signaling in a model of chronic bacterial infection.
Algood HM; Allen SS; Washington MK; Peek RM; Miller GG; Cover TL
J Immunol; 2009 Nov; 183(9):5837-46. PubMed ID: 19812196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
